Category: Moms

Fat metabolism regulation

Fat metabolism regulation

regupation the Study of Regulahion Toxicity Fat metabolism regulation, regulatino16 Natural focus enhancer Care 39, — Fatty acid transport protein 4 Fat metabolism regulation dispensable for intestinal lipid absorption in mice. The assembly and secretion of ApoB containing lipoproteins in Hep G2 cells. Fat composition Several groups have biochemically determined the composition of C. Role in β-cell adaptation and failure in the etiology of diabetes. Brooks-Wilson, A.

Fat metabolism regulation -

In another type of anabolism, fatty acids are modified to form other compounds such as second messengers and local hormones. The prostaglandins made from arachidonic acid stored in the cell membrane are probably the best-known of these local hormones.

Fatty acids are stored as triglycerides in the fat depots of adipose tissue. Between meals they are released as follows:.

In the liver oxaloacetate can be wholly or partially diverted into the gluconeogenic pathway during fasting, starvation, a low carbohydrate diet, prolonged strenuous exercise, and in uncontrolled type 1 diabetes mellitus.

Under these circumstances, oxaloacetate is hydrogenated to malate , which is then removed from the mitochondria of the liver cells to be converted into glucose in the cytoplasm of the liver cells, from where it is released into the blood.

Under these conditions, acetyl-CoA is diverted to the formation of acetoacetate and beta-hydroxybutyrate. The ketones are released by the liver into the blood. All cells with mitochondria can take up ketones from the blood and reconvert them into acetyl-CoA, which can then be used as fuel in their citric acid cycles, as no other tissue can divert its oxaloacetate into the gluconeogenic pathway in the way that this can occur in the liver.

Unlike free fatty acids, ketones can cross the blood—brain barrier and are therefore available as fuel for the cells of the central nervous system , acting as a substitute for glucose, on which these cells normally survive.

Fatty acids, stored as triglycerides in an organism, are a concentrated source of energy because they contain little oxygen and are anhydrous. The energy yield from a gram of fatty acids is approximately 9 kcal 37 kJ , much higher than the 4 kcal 17 kJ for carbohydrates.

Since the hydrocarbon portion of fatty acids is hydrophobic , these molecules can be stored in a relatively anhydrous water-free environment. Carbohydrates, on the other hand, are more highly hydrated.

For example, 1 g of glycogen binds approximately 2 g of water , which translates to 1. This means that fatty acids can hold more than six times the amount of energy per unit of stored mass.

Put another way, if the human body relied on carbohydrates to store energy, then a person would need to carry 31 kg Hibernating animals provide a good example for utilization of fat reserves as fuel. For example, bears hibernate for about 7 months, and during this entire period, the energy is derived from degradation of fat stores.

Migrating birds similarly build up large fat reserves before embarking on their intercontinental journeys. The fat stores of young adult humans average between about 10—20 kg, but vary greatly depending on gender and individual disposition.

The g or so of glycogen stored in the liver is depleted within one day of starvation. Fatty acids are broken down to acetyl-CoA by means of beta oxidation inside the mitochondria, whereas fatty acids are synthesized from acetyl-CoA outside the mitochondria, in the cytosol.

The two pathways are distinct, not only in where they occur, but also in the reactions that occur, and the substrates that are used. The two pathways are mutually inhibitory, preventing the acetyl-CoA produced by beta-oxidation from entering the synthetic pathway via the acetyl-CoA carboxylase reaction.

During each turn of the cycle, two carbon atoms leave the cycle as CO 2 in the decarboxylation reactions catalyzed by isocitrate dehydrogenase and alpha-ketoglutarate dehydrogenase.

Thus each turn of the citric acid cycle oxidizes an acetyl-CoA unit while regenerating the oxaloacetate molecule with which the acetyl-CoA had originally combined to form citric acid. The decarboxylation reactions occur before malate is formed in the cycle.

However, acetyl-CoA can be converted to acetoacetate, which can decarboxylate to acetone either spontaneously, or catalyzed by acetoacetate decarboxylase.

Acetol can be converted to propylene glycol. This converts to pyruvate by two alternative enzymes , or propionaldehyde , or to L -lactaldehyde then L -lactate the common lactate isomer.

The first experiment to show conversion of acetone to glucose was carried out in This, and further experiments used carbon isotopic labelling.

The glycerol released into the blood during the lipolysis of triglycerides in adipose tissue can only be taken up by the liver. Here it is converted into glycerol 3-phosphate by the action of glycerol kinase which hydrolyzes one molecule of ATP per glycerol molecule which is phosphorylated.

Glycerol 3-phosphate is then oxidized to dihydroxyacetone phosphate , which is, in turn, converted into glyceraldehyde 3-phosphate by the enzyme triose phosphate isomerase.

From here the three carbon atoms of the original glycerol can be oxidized via glycolysis , or converted to glucose via gluconeogenesis. Fatty acids are an integral part of the phospholipids that make up the bulk of the plasma membranes , or cell membranes, of cells.

These phospholipids can be cleaved into diacylglycerol DAG and inositol trisphosphate IP 3 through hydrolysis of the phospholipid, phosphatidylinositol 4,5-bisphosphate PIP 2 , by the cell membrane bound enzyme phospholipase C PLC.

One product of fatty acid metabolism are the prostaglandins , compounds having diverse hormone -like effects in animals.

Prostaglandins have been found in almost every tissue in humans and other animals. They are enzymatically derived from arachidonic acid, a carbon polyunsaturated fatty acid. Every prostaglandin therefore contains 20 carbon atoms, including a 5-carbon ring. They are a subclass of eicosanoids and form the prostanoid class of fatty acid derivatives.

The prostaglandins are synthesized in the cell membrane by the cleavage of arachidonate from the phospholipids that make up the membrane. This is catalyzed either by phospholipase A 2 acting directly on a membrane phospholipid, or by a lipase acting on DAG diacyl-glycerol.

The arachidonate is then acted upon by the cyclooxygenase component of prostaglandin synthase. This forms a cyclopentane ring roughly in the middle of the fatty acid chain. The reaction also adds 4 oxygen atoms derived from two molecules of O 2. The resulting molecule is prostaglandin G 2 , which is converted by the hydroperoxidase component of the enzyme complex into prostaglandin H 2.

This highly unstable compound is rapidly transformed into other prostaglandins, prostacyclin and thromboxanes. If arachidonate is acted upon by a lipoxygenase instead of cyclooxygenase, Hydroxyeicosatetraenoic acids and leukotrienes are formed.

They also act as local hormones. Prostaglandins have two derivatives: prostacyclins and thromboxanes. Prostacyclins are powerful locally acting vasodilators and inhibit the aggregation of blood platelets. Through their role in vasodilation, prostacyclins are also involved in inflammation.

They are synthesized in the walls of blood vessels and serve the physiological function of preventing needless clot formation, as well as regulating the contraction of smooth muscle tissue. Their name comes from their role in clot formation thrombosis.

A significant proportion of the fatty acids in the body are obtained from the diet, in the form of triglycerides of either animal or plant origin. The fatty acids in the fats obtained from land animals tend to be saturated, whereas the fatty acids in the triglycerides of fish and plants are often polyunsaturated and therefore present as oils.

These triglycerides cannot be absorbed by the intestine. The activated complex can work only at a water-fat interface. Therefore, it is essential that fats are first emulsified by bile salts for optimal activity of these enzymes. the fat soluble vitamins and cholesterol and bile salts form mixed micelles , in the watery duodenal contents see diagrams on the right.

The contents of these micelles but not the bile salts enter the enterocytes epithelial cells lining the small intestine where they are resynthesized into triglycerides, and packaged into chylomicrons which are released into the lacteals the capillaries of the lymph system of the intestines.

This means that the fat-soluble products of digestion are discharged directly into the general circulation, without first passing through the liver, unlike all other digestion products.

The reason for this peculiarity is unknown. The chylomicrons circulate throughout the body, giving the blood plasma a milky or creamy appearance after a fatty meal.

The fatty acids are absorbed by the adipocytes [ citation needed ] , but the glycerol and chylomicron remnants remain in the blood plasma, ultimately to be removed from the circulation by the liver.

The free fatty acids released by the digestion of the chylomicrons are absorbed by the adipocytes [ citation needed ] , where they are resynthesized into triglycerides using glycerol derived from glucose in the glycolytic pathway [ citation needed ].

These triglycerides are stored, until needed for the fuel requirements of other tissues, in the fat droplet of the adipocyte. The liver absorbs a proportion of the glucose from the blood in the portal vein coming from the intestines. After the liver has replenished its glycogen stores which amount to only about g of glycogen when full much of the rest of the glucose is converted into fatty acids as described below.

These fatty acids are combined with glycerol to form triglycerides which are packaged into droplets very similar to chylomicrons, but known as very low-density lipoproteins VLDL.

These VLDL droplets are processed in exactly the same manner as chylomicrons, except that the VLDL remnant is known as an intermediate-density lipoprotein IDL , which is capable of scavenging cholesterol from the blood.

This converts IDL into low-density lipoprotein LDL , which is taken up by cells that require cholesterol for incorporation into their cell membranes or for synthetic purposes e. the formation of the steroid hormones. The remainder of the LDLs is removed by the liver.

Adipose tissue and lactating mammary glands also take up glucose from the blood for conversion into triglycerides. This occurs in the same way as in the liver, except that these tissues do not release the triglycerides thus produced as VLDL into the blood.

All cells in the body need to manufacture and maintain their membranes and the membranes of their organelles.

Whether they rely entirely on free fatty acids absorbed from the blood, or are able to synthesize their own fatty acids from blood glucose, is not known.

The cells of the central nervous system will almost certainly have the capability of manufacturing their own fatty acids, as these molecules cannot reach them through the blood brain barrier.

Much like beta-oxidation , straight-chain fatty acid synthesis occurs via the six recurring reactions shown below, until the carbon palmitic acid is produced.

The diagrams presented show how fatty acids are synthesized in microorganisms and list the enzymes found in Escherichia coli.

FASII is present in prokaryotes , plants, fungi, and parasites, as well as in mitochondria. In animals as well as some fungi such as yeast, these same reactions occur on fatty acid synthase I FASI , a large dimeric protein that has all of the enzymatic activities required to create a fatty acid.

FASI is less efficient than FASII; however, it allows for the formation of more molecules, including "medium-chain" fatty acids via early chain termination. by transferring fatty acids between an acyl acceptor and donor.

They also have the task of synthesizing bioactive lipids as well as their precursor molecules. Elongation, starting with stearate , is performed mainly in the endoplasmic reticulum by several membrane-bound enzymes. The enzymatic steps involved in the elongation process are principally the same as those carried out by fatty acid synthesis , but the four principal successive steps of the elongation are performed by individual proteins, which may be physically associated.

Abbreviations: ACP — Acyl carrier protein , CoA — Coenzyme A , NADP — Nicotinamide adenine dinucleotide phosphate. Note that during fatty synthesis the reducing agent is NADPH , whereas NAD is the oxidizing agent in beta-oxidation the breakdown of fatty acids to acetyl-CoA. This difference exemplifies a general principle that NADPH is consumed during biosynthetic reactions, whereas NADH is generated in energy-yielding reactions.

The source of the NADPH is two-fold. NADPH is also formed by the pentose phosphate pathway which converts glucose into ribose, which can be used in synthesis of nucleotides and nucleic acids , or it can be catabolized to pyruvate.

In humans, fatty acids are formed from carbohydrates predominantly in the liver and adipose tissue , as well as in the mammary glands during lactation. The pyruvate produced by glycolysis is an important intermediary in the conversion of carbohydrates into fatty acids and cholesterol.

However, this acetyl CoA needs to be transported into cytosol where the synthesis of fatty acids and cholesterol occurs. This cannot occur directly. To obtain cytosolic acetyl-CoA, citrate produced by the condensation of acetyl CoA with oxaloacetate is removed from the citric acid cycle and carried across the inner mitochondrial membrane into the cytosol.

The oxaloacetate is returned to mitochondrion as malate and then converted back into oxaloacetate to transfer more acetyl-CoA out of the mitochondrion. Acetyl-CoA is formed into malonyl-CoA by acetyl-CoA carboxylase , at which point malonyl-CoA is destined to feed into the fatty acid synthesis pathway.

Acetyl-CoA carboxylase is the point of regulation in saturated straight-chain fatty acid synthesis, and is subject to both phosphorylation and allosteric regulation. Regulation by phosphorylation occurs mostly in mammals, while allosteric regulation occurs in most organisms.

Allosteric control occurs as feedback inhibition by palmitoyl-CoA and activation by citrate. When there are high levels of palmitoyl-CoA, the final product of saturated fatty acid synthesis, it allosterically inactivates acetyl-CoA carboxylase to prevent a build-up of fatty acids in cells.

Citrate acts to activate acetyl-CoA carboxylase under high levels, because high levels indicate that there is enough acetyl-CoA to feed into the Krebs cycle and produce energy. High plasma levels of insulin in the blood plasma e. after meals cause the dephosphorylation and activation of acetyl-CoA carboxylase, thus promoting the formation of malonyl-CoA from acetyl-CoA, and consequently the conversion of carbohydrates into fatty acids, while epinephrine and glucagon released into the blood during starvation and exercise cause the phosphorylation of this enzyme, inhibiting lipogenesis in favor of fatty acid oxidation via beta-oxidation.

Disorders of fatty acid metabolism can be described in terms of, for example, hypertriglyceridemia too high level of triglycerides , or other types of hyperlipidemia. These may be familial or acquired. Familial types of disorders of fatty acid metabolism are generally classified as inborn errors of lipid metabolism.

These disorders may be described as fatty acid oxidation disorders or as a lipid storage disorders , and are any one of several inborn errors of metabolism that result from enzyme or transport protein defects affecting the ability of the body to oxidize fatty acids in order to produce energy within muscles, liver, and other cell types.

When a fatty acid oxidation disorder affects the muscles, it is a metabolic myopathy. Moreover, cancer cells can display irregular fatty acid metabolism with regard to both fatty acid synthesis [44] and mitochondrial fatty acid oxidation FAO [45] that are involved in diverse aspects of tumorigenesis and cell growth.

Contents move to sidebar hide. Article Talk. Read Edit View history. Tools Tools. What links here Related changes Upload file Special pages Permanent link Page information Cite this page Get shortened URL Download QR code Wikidata item. Download as PDF Printable version.

Set of biological processes. Main article: Fatty acid synthesis. Main article: Citric acid cycle § Glycolytic end products are used in the conversion of carbohydrates into fatty acids. In: Biochemistry Fourth ed. New York: W. Freeman and Company. ISBN doi : PMID S2CID Pflügers Archiv: European Journal of Physiology.

Molecular Aspects of Medicine. PMC Jul J Neurosci. Feb J Cereb Blood Flow Metab. Biochemistry Fourth ed. Donald; Stafstrom, Carl E. ISSN Molecular Genetics and Metabolism. Diabetes 48, — Bahl, J. In vitro and in vivo suppression of gluconeogenesis by inhibition of pyruvate carboxylase.

Biochem Pharmacol 53, 67— Bailey, A. Antioxidant role for lipid droplets in a stem cell niche of Drosophila. Cell , — Band, G. Functional activation by glucagon of glucose 6-phosphatase and gluconeogenesis in the perfused liver of the fetal guinea pig. FEBS Lett , — Bansal, V. Statistical analysis strategies for association studies involving rare variants.

Nat Rev Genet 11, — Barlowe, C. Trends Cell Biol 13, — Cargo capture and bulk flow in the early secretory pathway. Annu Rev Cell Dev Biol 32, — Secretory protein biogenesis and traffic in the early secretory pathway. Genetics , — Bartelt, A.

Adipose tissue browning and metabolic health. Nat Rev Endocrinol 10, 24— Barthel, A. Novel concepts in insulin regulation of hepatic gluconeogenesis.

Am J Physiol Endocrinol Metab , E—E Bartuzi, P. CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL. Nat Commun 7, Bartz, R. Lipidomics reveals that adiposomes store ether lipids and mediate phospholipid traffic. J Lipid Res 48, — ER membrane phospholipids and surface tension control cellular lipid droplet formation.

Dev Cell 41, — Benador, I. Mitochondria bound to lipid droplets: where mitochondrial dynamics regulate lipid storage and utilization. Cell Metab 29, — Mitochondria bound to lipid droplets have unique bioenergetics, composition, and dynamics that support lipid droplet expansion.

Cell Metab 27, — Berge, K. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science , — Best, J. Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. Proc Natl Acad Sci USA , — Betz, M.

Targeting thermogenesis in brown fat and muscle to treat obesity and metabolic disease. Nat Rev Endocrinol 14, 77— Bhattacharyya, A. β-sitosterolemia and xanthomatosis. J Clin Invest 53, — Bi, X. Bianchi, P. Congenital dyserythropoietic anemia type II CDAII is caused by mutations in the SEC23B gene.

Hum Mutat 30, — Bickford, L. A structural view of the COPII vesicle coat. Curr Opin Struct Biol 14, — Bodzioch, M. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.

Nat Genet 22, — Boren, J. The assembly and secretion of ApoB containing lipoproteins in Hep G2 cells. ApoB is cotranslationally integrated into lipoproteins.

CAS PubMed Google Scholar. Bosner, M. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J Lipid Res 40, — Boström, P. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.

Boyadjiev, S. Cranio-lenticulo-sutural dysplasia is caused by a SEC23A mutation leading to abnormal endoplasmic-reticulum-to-Golgi trafficking. Nat Genet 38, — Cranio-lenticulo-sutural dysplasia associated with defects in collagen secretion.

Clin Genet 80, — Article PubMed PubMed Central Google Scholar. Brodsky, J. The many intersecting pathways underlying apolipoprotein B secretion and degradation. Trends Endocrinol Metab 19, — Brooks-Wilson, A. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.

Brown, A. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol Cell 10, — Brown, M. Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth.

J Lipid Res 21, — A receptor-mediated pathway for cholesterol homeostasis. Science , 34— The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

Cell 89, — J Lipid Res 50, S15—S Retrospective on cholesterol homeostasis: the central role of scap. Annu Rev Biochem 87, — Regulated intramembrane proteolysis. Brunham, L. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest , — Butkinaree, C.

A regulator of secretory vesicle size, Kelch-like protein 12, facilitates the secretion of apolipoprotein B and very-low-density lipoproteins—brief report. Arterioscler Thromb Vasc Biol 34, — Cano, N. Bench-to-bedside review: glucose production from the kidney. Crit Care 6, — Carneiro, L.

AMPK activation caused by reduced liver lactate metabolism protects against hepatic steatosis in MCT1 haploinsufficient mice. Mol Metab 6, — Cartwright, B. Seipin performs dissectible functions in promoting lipid droplet biogenesis and regulating droplet morphology.

Mol Biol Cell 26, — Castellano, B. Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex. Cermelli, S. The lipid-droplet proteome reveals that droplets are a protein-storage depot. Curr Biol 16, — César-Razquin, A. A call for systematic research on solute carriers.

Chakrabarti, P. Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage. Diabetes 59, — Chang, T. Acylcoenzyme A:cholesterol acyltransferases.

Am J Physiol Endocrinol Metab , E1—E9. Chen, L. OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin.

Chen, X. SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion. eLife 2, e Cho, J. Mitochondrial ATP transporter Ant2 depletion impairs erythropoiesis and B lymphopoiesis. Cell Death Differ 22, — Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance.

Nat Commun 8, Chorlay, A. Membrane asymmetry imposes directionality on lipid droplet emergence from the ER. Dev Cell 50, 25— Chouchani, E.

New advances in adaptive thermogenesis: UCP1 and beyond. Cell Metab 29, 27— Choudhary, V. A conserved family of proteins facilitates nascent lipid droplet budding from the ER.

J Cell Biol , — Chrivia, J. Phosphorylated CREB binds specifically to the nuclear protein CBP. Chu, B. Cholesterol transport through lysosome-peroxisome membrane contacts. Cohen, J. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

Nat Genet 37, — Sequence variations in PCSK9 , low LDL, and protection against coronary heart disease.

N Engl J Med , — Simple genetics for a complex disease. Consoli, A. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38, — Costet, P.

PCSK9 and LDL cholesterol: unravelling the target to design the bullet. Trends Biochem Sci 33, — Cypess, A. Identification and importance of brown adipose tissue in adult humans. Das, A. Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis. eLife 3, e Article PubMed Central CAS Google Scholar.

Datta, S. Cerebellar ataxia disease-associated Snx14 promotes lipid droplet growth at ER-droplet contacts. Davidson, C. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression.

PLoS ONE 4, e Davidson, N. A polipoprotein B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu Rev Nutr 20, — Dentin, R.

Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Dewey, F. Distribution and clinical impact of functional variants in 50, whole-exome sequences from the DiscovEHR study.

Di Paolo, G. Nat Rev Neurosci 12, — Saxena, R. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Ding, L. Seipin regulates lipid homeostasis by ensuring calcium-dependent mitochondrial metabolism.

EMBO J DiTullio, N. Biochem J , — Doege, H. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis. Gastroenterology , — Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia.

Dupuis, J. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42, — Durrington, P. Egan, J. Mechanism of hormone-stimulated lipolysis in adipocytes: translocation of hormone-sensitive lipase to the lipid storage droplet.

Proc Natl Acad Sci USA 89, — Ekberg, K. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting.

Eliahu, S. A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold. J Med Chem 53, — Emmer, B. The cargo receptor SURF4 promotes the efficient cellular secretion of PCSK9.

eLife 7, e Erion, D. Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein. Cell Metab 10, — Espenshade, P. Regulation of sterol synthesis in eukaryotes. Annu Rev Genet 41, — Exton, J.

Control of gluconeogenesis in liver. Fedoseienko, A. The COMMD family regulates plasma LDL levels and attenuates atherosclerosis through stabilizing the CCC complex in endosomal LDLR trafficking. Circ Res , — Fei, W. Seipin, adipogenesis and lipid droplets. Trends Endocrinol Metab 22, — Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast.

PLoS Genet 7, e Fernandez, H. The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.

Cell Death Differ 25, — Fischer, J. The gene encoding adipose triglyceride lipase PNPLA2 is mutated in neutral lipid storage disease with myopathy. Nat Genet 39, 28— Fisher, S. Fitzky, B. Mutations in the 7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome.

Proc Natl Acad Sci USA 95, — Flannick, J. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet 46, — Flynn, T. Association analysis of the SLC22A11 organic anion transporter 4 and SLC22A12 urate transporter 1 urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects.

Arthritis Res Ther 15, R Foody, J. J Clin Lipidol 10, — Foretz, M. Fotiadis, D. The SLC3 and SLC7 families of amino acid transporters.

Frescas, D. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. Fromme, J. The genetic basis of a craniofacial disease provides insight into COPII coat assembly.

Dev Cell 13, — Futema, M. J Med Genet 51, — Gandotra, S. Perilipin deficiency and autosomal dominant partial lipodystrophy.

Gao, M. The biogenesis of lipid droplets: lipids take center stage. Prog Lipid Res 75, Garcia, C. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein.

Garcia-Calvo, M. The target of ezetimibe is Niemann-Pick C1-Like 1 NPC1L1. Gatta, A. Piecing together the patchwork of contact sites.

Trends Cell Biol 27, — Ge, L. Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab 7, — Gelissen, I.

ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol 26, — Ghosh, M. Ubiquitin ligase COP1 controls hepatic fat metabolism by targeting ATGL for degradation.

Diabetes 65, — Gill, S. Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase. Cell Metab 13, — Gillon, A.

Vesicle-mediated ER export of proteins and lipids. Biochim Biophys Acta Mol Cell Biol Lipids , — Girard, J. Goldberg, A. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients.

J Clin Lipidol 5, — Goldstein, J. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. Regulation of the mevalonate pathway.

The LDL receptor. Arterioscler Thromb Vasc Biol 29, — A century of cholesterol and coronaries: from plaques to genes to statins. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol 1, 1— Protein sensors for membrane sterols.

Cell , 35— Gong, J. Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites.

Gong, X. Structural insights into the Niemann-Pick C1 NPC1 -mediated cholesterol transfer and Ebola infection. Gonzalez, E. The Akt kinases: isoform specificity in metabolism and cancer.

Cell Cycle 8, — Gonzalez, G. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine Cell 59, — Gordon, D. Microsomal triglyceride transfer protein: a protein complex required for the assembly of lipoprotein particles.

Trends Cell Biol 5, — Gouni-Berthold, I. Systematic review of published Phase 3 data on anti-PCSK9 monoclonal antibodies in patients with hypercholesterolaemia.

Br J Clin Pharmacol 82, — Graf, G. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. Granneman, J. Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 Abhd5 and adipose triglyceride lipase Atgl.

Greenberg, A. Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. Gross, D. Direct binding of triglyceride to fat storage-inducing transmembrane proteins 1 and 2 is important for lipid droplet formation.

Grundy, S. J Am Coll Cardiol 73, e—e Gu, Q. Genetic ablation of solute carrier family 7a3a leads to hepatic steatosis in zebrafish during fasting. Hepatology 60, — Guo, Y. Functional genomic screen reveals genes involved in lipid-droplet formation and utilization.

Gürkan, C. The COPII cage: unifying principles of vesicle coat assembly. Nat Rev Mol Cell Biol 7, — Haemmerle, G. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC Nat Med 17, — Halestrap, A.

The SLC16 gene family—Structure, role and regulation in health and disease. The monocarboxylate transporter family-Role and regulation.

IUBMB Life 64, — Hall, R. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. Han, J. The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. Hardie, D. AMPK: a nutrient and energy sensor that maintains energy homeostasis.

Nat Rev Mol Cell Biol 13, — Hariri, H. Mdm1 maintains endoplasmic reticulum homeostasis by spatially regulating lipid droplet biogenesis. Harms, M. Brown and beige fat: development, function and therapeutic potential.

Nat Med 19, — Hatting, M. Insulin regulation of gluconeogenesis. Ann NY Acad Sci , 21— He, G. ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin, and AP Hediger, M.

The ABCs ofmembrane transporters in health and disease SLC series : introduction. Mol Aspect Med 34, 95— Heid, I. Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions.

Circ Cardiovasc Genet 1, 10— Hemmings, B. Cold Spring Harb Perspect Biol 4, a Henderson, R. The genetics and screening of familial hypercholesterolaemia.

J Biomed Sci 23, Henne, W. The assembly of lipid droplets and their roles in challenged cells. Hers, H. Gluconeogenesis and related aspects of glycolysis. Annu Rev Biochem 52, — Herzig, S. CREB regulates hepatic gluconeogenesis through the coactivator PGC Hobbs, H.

Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1, — Hoffmann, T. A large electronic-health-record-based genome-wide study of serum lipids. Nat Genet 50, — Hogan, M. Hepatic insulin resistance following chronic activation of the CREB coactivator CRTC2.

Horton, J. Molecular biology of PCSK9: its role in LDL metabolism. Trends Biochem Sci 32, 71— PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res 50, S—S SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

Hossain, P. Obesity and diabetes in the developing world—a growing challenge. Hua, X. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein. Cell 87, — Huang, S. The GLUT4 glucose transporter. Cell Metab 5, — Huang, X. Region-specific requirement for cholesterol modification of sonic hedgehog in patterning the telencephalon and spinal cord.

Development , — Hubbard, B. Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity.

Hyde, C. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat Genet 48, — Iacobazzi, V. Citrate—new functions for an old metabolite. Biol Chem , — Infantino, V. A key role of the mitochondrial citrate carrier SLC25A1 in TNFα- and IFNγ-triggered inflammation.

Biochim Biophys Acta Gene Regulat Mech , — Ishigami, M. Temporary sequestration of cholesterol and phosphatidylcholine within extracellular domains of ABCA1 during nascent HDL generation.

Sci Rep 8, Izar, M. Phytosterols and phytosterolemia: gene-diet interactions. Genes Nutr 6, 17— Jansson, D. Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2.

Jerome, W. Lysosomes, cholesterol and atherosclerosis. Clin Lipidol 5, — Jiang, S. Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol. Nat Commun 9, Schnyder corneal dystrophy-associated UBIAD1 mutations cause corneal cholesterol accumulation by stabilizing HMG-CoA reductase.

PLoS Genet 15, e Jo, Y. Schnyder corneal dystrophy-associated UBIAD1 inhibits ER-associated degradation of HMG CoA reductase in mice.

eLife 8, e Johnson, M. Developmentally regulated H2Av buffering via dynamic sequestration to lipid droplets in Drosophila embryos. Jones, B.

Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet 34, 29— Joshi, A. Lipid droplet and peroxisome biogenesis occur at the same ER subdomains.

Kadereit, B. Evolutionarily conserved gene family important for fat storage. Proc Natl Acad Sci USA , 94— Kannel, W. Factors of risk in the development of coronary heart disease—six-year follow-up experience.

Ann Intern Med 55, Kathiresan, S. A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study. BMC Med Genet 8, S Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.

Nat Genet 40, — Kaushik, S. Degradation of lipid droplet-associated proteins by chaperone-mediated autophagy facilitates lipolysis. Nat Cell Biol 17, — Kazda, C.

Evaluation of efficacy and safety of the glucagon receptor antagonist LY in patients with type 2 diabetes: and week Phase 2 studies.

Dia Care 39, — Kazierad, D. Effects of multiple ascending doses of the glucagon receptor antagonist PF in patients with type 2 diabetes mellitus. Diabetes Obes Metab 18, — Kc, S. Vitamin C enters mitochondria via facilitative glucose transporter 1 Glut1 and confers mitochondrial protection against oxidative injury.

FASEB J 19, — Khachadurian, A. The inheritance of essential familial hypercholesterolemia. Am J Med 37, — Experiences with the homozygous cases of familial hypercholesterolemia. Ann Nutr Metab 15, — Khoriaty, R. Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo. Proc Natl Acad Sci USA , E—E Article PubMed CAS PubMed Central Google Scholar.

Kimmel, A. The Perilipins: major cytosolic lipid droplet-associated proteins and their roles in cellular lipid storage, mobilization, and systemic homeostasis. Annu Rev Nutr 36, — Klarin, D.

Koepsell, H. The SLC22 family with transporters of organic cations, anions and zwitterions. Kolovou, G. Tangier disease four decades of research: a reflection of the importance of HDL. Curr Med Chem 13, — Koo, S.

The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Kooner, J. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Kory, N.

Targeting fat: mechanisms of protein localization to lipid droplets. Trends Cell Biol 26, — Protein crowding is a determinant of lipid droplet protein composition. Dev Cell 34, — Kotani, K. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.

Krahmer, N. Phosphatidylcholine synthesis for lipid droplet expansion is mediated by localized activation of CTP:phosphocholine cytidylyltransferase. Cell Metab 14, — Kumar, N. Identification of SR ML : a synthetic RORα selective inverse agonist. ACS Chem Biol 6, — Kurland, I. Protein Sci 4, — Kwok, R.

Nuclear protein CBP is a coactivator for the transcription factor CREB. Kwon, H. Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. The structure of the NPC1L1 N-Terminal domain in a closed conformation. PLoS ONE 6, e Lagace, T. PCSK9 and LDLR degradation.

Curr Opin Lipidol 25, — Lang, M. Secretory COPII coat component Sec23a is essential for craniofacial chondrocyte maturation.

Metrics details. Optimal pancreatic β-cell Regupation is essential for the regulatiion of glucose homeostasis in both metabolizm and animals and its impairment leads to the development Fat metabolism regulation diabetes. Type metaolism diabetes Buy Amazon Products a polygenic disease aggravated by environmental factors such as low physical activity or a hypercaloric high-fat diet. Free fatty acids represent an important factor linking excess fat mass to type 2 diabetes. Several studies have shown that chronically elevated free fatty acids have a negative effect on β-cell function leading to elevated insulin secretion basally but with an impaired response to glucose.

Video

Metabolism - Fatty Acid Oxidation: Part 1

Author: Samurn

0 thoughts on “Fat metabolism regulation

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com